Robert Thorvald Nagel
CIK: 0002113417
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IMUX
IMMUNIC, INC.
Director
Discretionary Trading P&L
Holdings
About Nagel Robert Thorvald
Nagel Robert Thorvald (SEC CIK 0002113417) files insider reports with the SEC as Director of IMMUNIC, INC. (IMUX).
Signal8 holds 2 ownership filings by Nagel Robert Thorvald (1 Form 3, 1 Form 4), filed between Feb 27, 2026 and Sep 18, 2026. Those filings report 1 transaction, the latest on Sep 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Nagel Robert Thorvald's filings is in NEW YORK, NY.
Recent filings by Nagel Robert Thorvald
- Sep 16, 2026: Grant or award of IMUX derivative securities (Form 4, code A).
Other insiders filing for IMMUNIC, INC. (IMUX)
- BVF PARTNERS L P/IL, Director
- Ridloff Elena, Director
- Skerjanec Simona, Director
- Rudick Richard Alan, Director
- PHILLIPS BARCLAY A, Director
- Neermann Joerg, Director